Latest stories on LSTA
LSTA pivots to cardioendocrine pipeline as $225 million private placement reshapes ownership
September 17, 2026
MarketChameleon42 · neutralgeneral
LISATA THERAPEUTICS, INC. (LSTA) files 8-K
SEC 8-K50 · neutralgeneral
Lisata Therapeutics Announces Acquisition of Marea Therapeutics and $225 Million Concurrent Private Placement
GlobeNewswire63 · neutralm&a
Lisata Therapeutics moves forward with legal action following Kuva merger termination
Yahoo Top44 · neutralgeneral
Lisata Therapeutics Provides Update Following Termination of Merger Agreement
Business Insider32 · bearishm&a
Lisata Therapeutics Announces Major Workforce Reduction and Retrenchment
TipRanks28 · bearishgeneral
LISATA THERAPEUTICS, INC. (LSTA) files 8-K
SEC 8-K50 · neutralgeneral
Lisata Therapeutics plunges after sale to Kuva Labs terminated
Seeking Alpha33 · bearishm&a
Lisata Therapeutics Ends Kuva Merger, Starts Strategic Review
TipRanks42 · neutralm&a
LISATA THERAPEUTICS, INC. (LSTA) files 8-K
SEC 8-K42 · neutralgeneral
Lisata Therapeutics Extends Merger Timeline with Kuva Labs
TipRanks55 · neutralm&a
LISATA THERAPEUTICS, INC. (LSTA) files 8-K
SEC 8-K50 · neutralgeneral
Lisata Therapeutics agrees to Kuva Labs buyout at $4 per share
Yahoo Finance52 · neutralm&a
Lisata Therapeutics Announces Commencement of Tender Offer by Kuva Labs Inc. | LSTA Stock News
StockTitan50 · neutralm&a
Lisata Therapeutics Announces Commencement of Tender Offer by Kuva Labs Inc.
GlobeNewswire48 · neutralm&a
Lisata Therapeutics Amends Kuva Labs Merger Agreement Timeline
TipRanks56 · neutralm&a
LISATA THERAPEUTICS, INC. (LSTA) files 8-K
SEC 8-K50 · neutralgeneral
Lisata Therapeutics Faces Uncertainty in Kuva Tender Offer
TipRanks42 · neutralgeneral
Are SILA, KALV, THR, LSTA Obtaining Fair Deals for their Shareholders?
PR Newswire48 · neutralgeneral